Loading…

Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block

Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1....

Full description

Saved in:
Bibliographic Details
Published in:Journal of Pharmacological Sciences 2008, Vol.108(1), pp.49-55
Main Authors: Aréchiga, Iván A., Barrio-Echavarria, Gabriel F., Rodríguez-Menchaca, Aldo A., Moreno-Galindo, Eloy G., Decher, Niels, Tristani-Firouzi, Martin, Sánchez-Chapula, José A., Navarro-Polanco, Ricardo A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143
cites cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143
container_end_page 55
container_issue 1
container_start_page 49
container_title Journal of Pharmacological Sciences
container_volume 108
creator Aréchiga, Iván A.
Barrio-Echavarria, Gabriel F.
Rodríguez-Menchaca, Aldo A.
Moreno-Galindo, Eloy G.
Decher, Niels
Tristani-Firouzi, Martin
Sánchez-Chapula, José A.
Navarro-Polanco, Ricardo A.
description Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.
doi_str_mv 10.1254/jphs.08084FP
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319313738</els_id><doaj_id>oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81</doaj_id><sourcerecordid>18818480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</originalsourceid><addsrcrecordid>eNptkcGO0zAQhiMEYpeFG2fkB6BdT-IkDrelpeyKRcsBztbUnjQOiRPZ6Up9e9ymlAsHjy3P729mfifJe-BLSHNx245NWHLJpdj8eJFcQybKhSyEfHk5Q3aVvAmh5TyVHIrXyRVICVJIfp3gt2dY5uxpJMdWDTpHHfvcDfo32x7Y1BC7c5NF75vD1PRWs7Xf79jahmE8eOytoU_s-9CR3nfo2Zom8r116KbAhnoGvU1e1dgFenfeb5Jfmy8_V_eLx6evD6u7x4UuIZ0WKLgRgpe1EWBKMCLNamOK3JCUFRaG6tJwBNQIYPKs1lVGeQWQiywzBkR2kzzMXDNgq0Zve_QHNaBVp4vB7xT6yeqOFKEpTUrbkh_roKnygrLSFHVWCjISIuvjzNJ-CMFTfeEBV0fX1dF1dXY9yj_M8nG_7cn8E59tjoLNLIhZq7EbXGcdqXbYexc9UbougrbkVMq5VBwiGBTnRVyiiiHPJU-5kBG0nkFtmHBHl0p_Jzu1FZ8rOMVzg5e0btArchFTzBiKH_JsyatTeR2786Sn6Jj9_6R_AC5vvzs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><source>ScienceDirect Journals</source><creator>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A.</creator><creatorcontrib>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A. ; Department of Pediatric of Cardiology ; University of Utah ; Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima ; Philipps-University ; Institute of Physiology</creatorcontrib><description>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.08084FP</identifier><identifier>PMID: 18818480</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Alanine - genetics ; Anti-Arrhythmia Agents - pharmacology ; antiarrhythmic ; Cell Line ; Data Interpretation, Statistical ; disopyramide ; Disopyramide - pharmacology ; Humans ; Kv1.5 ; Kv1.5 Potassium Channel - chemistry ; Kv1.5 Potassium Channel - drug effects ; Kv1.5 Potassium Channel - genetics ; Mutagenesis - drug effects ; Patch-Clamp Techniques ; potassium channel ; Potassium Channel Blockers ; ultra rapid delayed rectifier</subject><ispartof>Journal of Pharmacological Sciences, 2008, Vol.108(1), pp.49-55</ispartof><rights>2008 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</citedby><cites>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319313738$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18818480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aréchiga, Iván A.</creatorcontrib><creatorcontrib>Barrio-Echavarria, Gabriel F.</creatorcontrib><creatorcontrib>Rodríguez-Menchaca, Aldo A.</creatorcontrib><creatorcontrib>Moreno-Galindo, Eloy G.</creatorcontrib><creatorcontrib>Decher, Niels</creatorcontrib><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Sánchez-Chapula, José A.</creatorcontrib><creatorcontrib>Navarro-Polanco, Ricardo A.</creatorcontrib><creatorcontrib>Department of Pediatric of Cardiology</creatorcontrib><creatorcontrib>University of Utah</creatorcontrib><creatorcontrib>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</creatorcontrib><creatorcontrib>Philipps-University</creatorcontrib><creatorcontrib>Institute of Physiology</creatorcontrib><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</description><subject>Alanine - genetics</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>antiarrhythmic</subject><subject>Cell Line</subject><subject>Data Interpretation, Statistical</subject><subject>disopyramide</subject><subject>Disopyramide - pharmacology</subject><subject>Humans</subject><subject>Kv1.5</subject><subject>Kv1.5 Potassium Channel - chemistry</subject><subject>Kv1.5 Potassium Channel - drug effects</subject><subject>Kv1.5 Potassium Channel - genetics</subject><subject>Mutagenesis - drug effects</subject><subject>Patch-Clamp Techniques</subject><subject>potassium channel</subject><subject>Potassium Channel Blockers</subject><subject>ultra rapid delayed rectifier</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkcGO0zAQhiMEYpeFG2fkB6BdT-IkDrelpeyKRcsBztbUnjQOiRPZ6Up9e9ymlAsHjy3P729mfifJe-BLSHNx245NWHLJpdj8eJFcQybKhSyEfHk5Q3aVvAmh5TyVHIrXyRVICVJIfp3gt2dY5uxpJMdWDTpHHfvcDfo32x7Y1BC7c5NF75vD1PRWs7Xf79jahmE8eOytoU_s-9CR3nfo2Zom8r116KbAhnoGvU1e1dgFenfeb5Jfmy8_V_eLx6evD6u7x4UuIZ0WKLgRgpe1EWBKMCLNamOK3JCUFRaG6tJwBNQIYPKs1lVGeQWQiywzBkR2kzzMXDNgq0Zve_QHNaBVp4vB7xT6yeqOFKEpTUrbkh_roKnygrLSFHVWCjISIuvjzNJ-CMFTfeEBV0fX1dF1dXY9yj_M8nG_7cn8E59tjoLNLIhZq7EbXGcdqXbYexc9UbougrbkVMq5VBwiGBTnRVyiiiHPJU-5kBG0nkFtmHBHl0p_Jzu1FZ8rOMVzg5e0btArchFTzBiKH_JsyatTeR2786Sn6Jj9_6R_AC5vvzs</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Aréchiga, Iván A.</creator><creator>Barrio-Echavarria, Gabriel F.</creator><creator>Rodríguez-Menchaca, Aldo A.</creator><creator>Moreno-Galindo, Eloy G.</creator><creator>Decher, Niels</creator><creator>Tristani-Firouzi, Martin</creator><creator>Sánchez-Chapula, José A.</creator><creator>Navarro-Polanco, Ricardo A.</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>2008</creationdate><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><author>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Alanine - genetics</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>antiarrhythmic</topic><topic>Cell Line</topic><topic>Data Interpretation, Statistical</topic><topic>disopyramide</topic><topic>Disopyramide - pharmacology</topic><topic>Humans</topic><topic>Kv1.5</topic><topic>Kv1.5 Potassium Channel - chemistry</topic><topic>Kv1.5 Potassium Channel - drug effects</topic><topic>Kv1.5 Potassium Channel - genetics</topic><topic>Mutagenesis - drug effects</topic><topic>Patch-Clamp Techniques</topic><topic>potassium channel</topic><topic>Potassium Channel Blockers</topic><topic>ultra rapid delayed rectifier</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aréchiga, Iván A.</creatorcontrib><creatorcontrib>Barrio-Echavarria, Gabriel F.</creatorcontrib><creatorcontrib>Rodríguez-Menchaca, Aldo A.</creatorcontrib><creatorcontrib>Moreno-Galindo, Eloy G.</creatorcontrib><creatorcontrib>Decher, Niels</creatorcontrib><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Sánchez-Chapula, José A.</creatorcontrib><creatorcontrib>Navarro-Polanco, Ricardo A.</creatorcontrib><creatorcontrib>Department of Pediatric of Cardiology</creatorcontrib><creatorcontrib>University of Utah</creatorcontrib><creatorcontrib>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</creatorcontrib><creatorcontrib>Philipps-University</creatorcontrib><creatorcontrib>Institute of Physiology</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aréchiga, Iván A.</au><au>Barrio-Echavarria, Gabriel F.</au><au>Rodríguez-Menchaca, Aldo A.</au><au>Moreno-Galindo, Eloy G.</au><au>Decher, Niels</au><au>Tristani-Firouzi, Martin</au><au>Sánchez-Chapula, José A.</au><au>Navarro-Polanco, Ricardo A.</au><aucorp>Department of Pediatric of Cardiology</aucorp><aucorp>University of Utah</aucorp><aucorp>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</aucorp><aucorp>Philipps-University</aucorp><aucorp>Institute of Physiology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2008</date><risdate>2008</risdate><volume>108</volume><issue>1</issue><spage>49</spage><epage>55</epage><pages>49-55</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>18818480</pmid><doi>10.1254/jphs.08084FP</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-8613
ispartof Journal of Pharmacological Sciences, 2008, Vol.108(1), pp.49-55
issn 1347-8613
1347-8648
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81
source ScienceDirect Journals
subjects Alanine - genetics
Anti-Arrhythmia Agents - pharmacology
antiarrhythmic
Cell Line
Data Interpretation, Statistical
disopyramide
Disopyramide - pharmacology
Humans
Kv1.5
Kv1.5 Potassium Channel - chemistry
Kv1.5 Potassium Channel - drug effects
Kv1.5 Potassium Channel - genetics
Mutagenesis - drug effects
Patch-Clamp Techniques
potassium channel
Potassium Channel Blockers
ultra rapid delayed rectifier
title Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kv1.5%20Open%20Channel%20Block%20by%20the%20Antiarrhythmic%20Drug%20Disopyramide:%20Molecular%20Determinants%20of%20Block&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Ar%C3%A9chiga,%20Iv%C3%A1n%20A.&rft.aucorp=Department%20of%20Pediatric%20of%20Cardiology&rft.date=2008&rft.volume=108&rft.issue=1&rft.spage=49&rft.epage=55&rft.pages=49-55&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.08084FP&rft_dat=%3Cpubmed_doaj_%3E18818480%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18818480&rfr_iscdi=true